ActivePure® is the leading air purifier technology to reduce harmful contaminants in the air and on surfaces. The technology has a proven track record and is supported by exhaustive testing in laboratory and real-world settings.
Reduces over 99.9% of airborne and surface SARS-CoV-2 viral particles, (the virus that causes COVID-19)*
Both airborne and surface virus reduction such as; H5N8, H1N1, RNA, and DNA viruses.*
Gram-positive and negative airborne and surface bacteria such as; Staphylococcus and Erwina Herbicola.*
Volatile Organic Compounds (VOCs), Gases, and TVOCs such as Formaldehyde.*
Smoke reduction, such as particulate matter between PM 0.8 and PM 2.5.*
Fungi and mold, airborne and surface. Including Aspergillus Niger and Bacillus Globigi.*
ActivePure continues to work with independent third-party laboratories, conduct real-world testing, and support peer-reviewed testing to be a leader in demonstrated technology efficacy and safety. To learn more about our test results and performance efficacy, see our summary of results below.
99.96%
Results are based on testing conducted at UTMB (University of Texas Medical Branch) BSLLevel 3 Lab with assistance from BSL Level 4 Lab, complying with FDA protocols in an FDA Certified Laboratory (Unit tested: Aerus Pure & Clean).
99.98%
Results are based on testing conducted at MRIGlobal, an independent, FDA Certified laboratory. The reduction percentages were measured incrementally over the natural degradation of SARS-CoV-2. Outside of control group - over 99.9%reduction of the SARS-CoV-2 virus (Unit tested: Aerus Hydroxyl Blaster).
85%
Results are based on laboratory testing conducted to demonstrate the use of ActivePure® Technology in substantially reducing airborne contaminants. Field results may vary based on environmental conditions. These results have not been evaluated by the FDA.
99.99%
Results are based on testing conducted at Aerosol Research and Engineering Laboratories, a 3rd-party unaffiliated laboratory with no connection to ActivePure or its affiliates. Net log reduction of Aspergillus Niger (fungal spores) (Unit tested: ActivePure Medical Guardian).
99.99%
Results are based on testing conducted at Aerosol Research and Engineering Laboratories, a 3rd-party unaffiliated laboratory with no connection to ActivePure or its affiliates. Net log reduction of Bacillus Globigii (bacterial spores) (Unit tested: ActivePure Medical Guardian).
99.99%
Results are based on testing conducted at Aerosol Research and Engineering Laboratories, a 3rd-party unaffiliated laboratory with no connection to ActivePure or its affiliates. Net log reduction Phi-X174 Bacteriophage DNA Virus bioaerosol (Unit tested: ActivePure Medical Guardian).
*These results have not been cleared by the FDA, but are the subject of filings with the FDA for clearance.
“Keeping patients and team members safe is the top priority for infection prevention and control, and as HAIs in healthcare continue to rise and occur. I am proud to highlight the improvements we made with ActivePure.”
Lori Berthelot, RN, BSN, CIC, Infection Control Supervisor
Ochsner Health, Louisiana, USA
Improve the health of your building with Sanalife's scalable air purification and indoor air quality monitoring solutions. Gain insights and analyze the air quality across your entire portfolio of assets.
Our mission is to educate and raise awareness about the significance of indoor air quality and sustainability and the big impact small lifestyle changes can have on the environment around us.
We're dedicated to providing advanced energy management and indoor air quality solutions to schools, businesses, and organizations across the United States.
©2023 InTech Energy Inc. DBA Sanalife and E360. All rights reserved. Various trademarks held by their respective owners.
